Annalisa Capuano is a medical doctor specialized in Clinical Pharmacology. She plays her research activities as Associate Professor at the Department of Experimental Medicine – University of Campania “Luigi Vanvitelli”. She is the responsabile of the Regional Centre of Pharmacovigilance and Pharmacoepidemiology (Campania region – South of Italy). Her research activities are directed to the topics of pharmacology in a broad sense, pharmacovigilance, pharmacoepidemiology and proper use of medicines and vaccines.
Areas of expertise include: Clinical research studies for the evaluation of safety and efficacy of drugs in the pre-and post-marketing phases; Methods (meta-analyses, data-mining techniques) for the evaluation of the efficacy and safety of biotech drugs in humans, including vaccines; Epidemiology techniques applied to the drug use and appropriateness of medicines’ use; Techniques for the study of drug toxicity in humans; Biomedical techniques for the evaluation of the risk / benefit profile of cell, gene and immunotherapy therapies in the oncology field.
Since 2004, she is a member (pharmacologist) of the section of Clinical Pharmacology of Italian Society of Pharmacology. She is also member pharmacologist of two Ethics Committees in the Campania region. She has been collaborating for many years with the National Institute of Health (National Center for Epidemiology, surveillance and health promotion). During her carrier she has obtained national funding for research projects by the Italian Medicine Agency (AIFA) and by the Italian Ministry of Education and University. She is also a member of the Secretariat of Pharmacovigilance at AIFA and component of ENCePP at EMA. Her research activities have led to over 150 publications in international journals.